Fulgent Genetics (FLGT) Cash from Operations Growth (3y) (2018 - 2026)
Powered by 
Analysis
Fulgent Genetics (FLGT) Cash from Operations Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 39.21% |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 10.37% |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 8.23% |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 14.98% |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | - |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 31.29% |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 35.23% |
| 10 | Fulgent Genetics | 596.80 Mn | 334.14 Mn | 25.68 Mn | -64.36% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -64.36% |
| Mar 31, 2026 | 42.56% |
| Dec 31, 2025 | -63.28% |
| Sep 30, 2025 | -18.84% |
| Jun 30, 2025 | -67.65% |
| Mar 31, 2025 | -26.48% |
| Dec 31, 2024 | -31.28% |
| Sep 30, 2024 | -28.10% |
| Jun 30, 2024 | -61.67% |
| Mar 31, 2024 | -68.53% |
| Dec 31, 2023 | -51.91% |
| Sep 30, 2023 | 2.84% |
| Jun 30, 2023 | 61.45% |
| Mar 31, 2023 | -98.22% |
| Dec 31, 2022 | 560.59% |
| Sep 30, 2022 | 74.60% |
| Jun 30, 2022 | 154.49% |
| Mar 31, 2022 | 463.14% |
| Dec 31, 2021 | 362.73% |
| Sep 30, 2021 | 1,032.25% |